immune system, prematurity
Conditions
Interventions
Group 1: Preterm infants <32 weeks of gestational age who are being treated at the University Medical Center Freiburg, Department of Neonatology and Pediatric Intensive Care, and who undergo a blood d
the results will be compared with those from the initial analysis.
Sponsors
Universitätsklinikum Freiburg, Institut für Infektionsprävention und Krankenhaushygiene
Eligibility
Sex/Gender
All
Age
No minimum to 7 Days
Inclusion criteria
Inclusion criteria: Prematurity <32 weeks postmenstrual age
Exclusion criteria
Exclusion criteria: Lack of informed consent by legal gaurdians
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Concordance of the relative counts of the immune cell populations assessed by FACS and epigenetic PCR. | — |
Secondary
| Measure | Time frame |
|---|---|
| Stability of dried blood spots for epigenetic immune-cell analyses (12 months) | — |
Countries
Germany
Contacts
Public ContactMartin Kuntz
Universitätsklinikum Freiburg, Klinik für Allgemeine Kinder- und Jugendmedizin, Sektion Neonatologie und pädiatrische Intensivmedizin
Outcome results
None listed